Edition:
India

Lipocine Inc (LPCN.OQ)

LPCN.OQ on NASDAQ Stock Exchange Capital Market

1.34USD
18 Jun 2018
Change (% chg)

$-0.05 (-3.96%)
Prev Close
$1.39
Open
$1.39
Day's High
$1.39
Day's Low
$1.33
Volume
5,484
Avg. Vol
52,284
52-wk High
$5.32
52-wk Low
$1.03

Select another date:

Wed, May 9 2018

BRIEF-Lipocine Receives Complete Response Letter For Tlando From U.S. FDA

* LIPOCINE RECEIVES COMPLETE RESPONSE LETTER FOR TLANDO FROM U.S. FOOD AND DRUG ADMINISTRATION

BRIEF-Lipocine Announces Q1 Loss Per Share $0.13

* LIPOCINE ANNOUNCES FINANCIAL AND OPERATIONAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2018

BRIEF-Lipocine Says ‍As Of December 31, 2017 Co Had Cash, Cash Equivalents And Marketable Securities Of $21.5 Mln​

* LIPOCINE ANNOUNCES FINANCIAL AND OPERATIONAL RESULTS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2017

BRIEF-Lipocine Announces Settlement Of Securities Class Action Lawsuit

* LIPOCINE ANNOUNCES SETTLEMENT OF SECURITIES CLASS ACTION LAWSUIT

BRIEF-Lipocine Announces $10 Mln Loan And Security Agreement With Silicon Valley Bank

* LIPOCINE ANNOUNCES $10 MILLION LOAN AND SECURITY AGREEMENT WITH SILICON VALLEY BANK Source text for Eikon: Further company coverage:

BRIEF-Lipocine Says FDA's BRUDAC Voted 6 In Favor & 13 Against Benefit/Risk Profile Of Tlando

* LIPOCINE - FDA'S BRUDAC VOTED 6 IN FAVOR & 13 AGAINST BENEFIT/RISK PROFILE OF CO'S ORAL TESTOSTERONE PRODUCT CANDIDATE FOR TRT IN ADULT MALES, TLANDO

BRIEF-Lipocine Says On Jan 5, Co, Unit, Silicon Valley Bank Entered Into Loan, Security Agreement

* LIPOCINE INC SAYS ON JAN 5, CO, UNIT, SILICON VALLEY BANK ("SVB") ENTERED INTO A LOAN AND SECURITY AGREEMENT -SEC FILING

Select another date: